top of page
![Sensirion_edited.jpg](https://static.wixstatic.com/media/d3dc8c_d85fa8c688f0455ea1da6f6a1e812d55~mv2.png/v1/fill/w_497,h_269,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Sensirion_edited.png)
Polyneuron Pharmaceuticals
Health & Nutrition
Polyneuron develops a new drug class for the treatment of autoimmune diseases affecting the nervous system. Their Antibody-Catchâ„¢ platform technology enables the rational design of immunomodulatory compounds that selectively eliminate disease-causing autoantibodies. The platform carries the potential to realize breakthrough therapies for specific autoimmune conditions.
![2000_W1_Carbofix.png](https://static.wixstatic.com/media/d3dc8c_9a96e08ebe484a52b801d18f294055b4~mv2.png/v1/fill/w_180,h_74,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/2000_W1_Carbofix.png)
2014
bottom of page